This post shows your complete mis understanding of the current...

First 117 Last

Share
Profile

Follow
brick6

589 Posts.

168

01/09/24

18:00

Post #: 75477057
Share

Originally posted by Shortblack: ↑

Point 1: The little office in Sydney that AKP is run out of spends $1.2 - $1.5 mil a year on admin/compliance. Fred & Shawn are incompetent & the company is badly managed ? I agree.

Point 2: Despite the pumping and promises last year of a completed product being ready to sell by the end of the year, they were unable to find sufficient finance or capital before the end of 2023 to prove that the company could continue as a going concern for the next 12 months. They were suspended immediately.
In the Dec 2023 report they stated they would continue their search for funding via convertible notes, placement of shares or additional loan facilities. They are & have been unable/unwilling to offer shares to existing holders for a number of reasons - compliance & disclosure for starters.
They been completely unsucessful, largely because they are in suspension. They can't issue shares to anyone & no one is going to take up convertible notes because their access to the market is closed.
To say that this was Fred's master plan, i.e. to be left holding the bag as the only source of ongoing funding is simply nonsense.

Question now is are the existing noteholders going to extend more time to Fred (for a second or third time) or will some of them want to cash in their chips at the end of this month when they fall due.
If some of them decide to cash out, Fred is going to have to come up with potentially a few million$ at the end of the month on top of the ongoing $400 - 500k per month in working capital needed if he wants to keep AKP alive. And you're saying he intentionlly put himself in this position ?

If the noteholders want their money back, it may be a better plan to wind up AKP and Fred and the other unsecured creditors can fight it out over possession of the private entity AP.
AP & it's IP would be easier to sell off than AKP at the end of the day.

Expand

This post shows your complete mis understanding of the current situation.

AKP Price at posting: $6.20 Sentiment: Hold Disclosure: Held
9 Upvote

2 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 53 more messages in this thread...

First 117 Last

Add AKP (ASX) to my watchlist

(20min delay)
Last $6.20		Change 0.000(0.00%)		Mkt cap ! $181.1M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

This post shows your complete mis understanding of the current...

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News

This post shows your complete mis understanding of the current...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News